Revance has appointed Ulta Beauty and Procter & Gamble alum Janelle Wichmann as its new chief marketing officer, skincare as it looks to boost commercial penetration of its Botox rival Daxxify.

Valeris’ newly appointed chief strategy officer Lauren Cole comes from Merck subsidary Verona Pharma, where she headed up patient services.

Biokin Pharma’s iza-bren, a first-in-class antibody-drug conjugate partnered with Bristol Myers Squibb, has posted another positive phase 3 readout.

After a year of impairments, revenue downgrades and the ousting of its chief executive officer, Australian plasma and vaccine specialist CSL has flashed signs of recovery, projecting mid-single-digit growth in fiscal year 2027 for its largest sector, CSL Behring.

CMI Media Group has stepped up its play for the orphan drug marketing sector, unveiling a framework tailored to the promotion of complex, low-incidence therapies.

After investors blanched last month at a slower-than-expected launch timeline for Celcuity’s novel breast cancer med Revtorpyk, the company used much of its latest earnings call to address concerns over—and reaffirm confidence in—the pace of its expected rollout.